Print Page   |   Contact Us   |   Sign In   |   Become a Member
Site Search
Member Profile
Blog Home All Blogs
Search all posts for:   

 

View all (37) posts »
 

Featured Member: David Scadden, MD

Posted By ISEH Headquarters, Thursday, April 01, 2010
Updated: Friday, October 01, 2010

David Scadden, MD
2010-2011 ISEH President

Dr. David Scadden is the Gerald and Darlene Jordan Professor of Medicine at Harvard University. He and Professor Douglas Melton founded and jointly direct the Harvard Stem Cell Institute which is the largest institute dedicated to bringing stem cell biology to medical care in the world. With Professor Melton, Professor Scadden founded and co-chairs the Department of Stem Cell and Regenerative Biology at Harvard University, the first department to span faculties in Harvard's 371-year history.
He is a hematologist/oncologist and directs the Center for Regenerative Medicine at the Massachusetts General Hospital (MGH) while also chairing the hematologic malignancies program in the MGH Cancer Center.
He is an expert on the medical applications of stem cell biology with a particular emphasis on their use in the settings of cancer and AIDS. He has published more than 250 scientific papers and book chapters, and his laboratory has made fundamental contributions regarding how the stem cell niche regulates stem cell function, in defining the molecules limiting stem cell growth, and in discovering a molecular basis for stem cell aging.
Dr. Scadden is the recipient of numerous honors including membership in the Institute of Medicine of the National Academies of Science and awards from the Doris Duke Charitable Trust, the Ellison Medical Foundation, the Burroughs Wellcome Fund, and the Leukemia and Lymphoma Society.
He has served or serves on the Board of Scientific Counselors for the National Cancer Institute, the Board of External Experts for the National Heart, Lung, and Blood Institute, Board of Directors of the International Society for Stem Cell Research, and ISEH. He is an associate member of the Broad Institute of Harvard and MIT. He serves on multiple editorial boards and scientific advisory boards and is a scientific founder of Fate Therapeutics, a private biotechnology company.

This post has not been tagged.

Share |
Permalink | Comments (0)
 
Association Management Software Powered by YourMembership.com®  ::  Legal